Zobrazeno 1 - 10
of 55
pro vyhledávání: '"R. Potì"'
Autor:
Nimish Vakil, R. Potì, Luigi Gatta, Cesare Hassan, F. Fornari, C. Papadia, M. Miglioli, A. Savioli, Antonio Merla, Francesco Perri, S. Morini, S. Campo, V. Rinaldi, D. Faleo, Claudio Ricci, Dino Vaira, Enzo Ierardi, S. Pilati, F. Perna, L. S. Mete, Angelo Zullo, V. De Francesco, G. Marinone, A. Tampieri, M Menegatti
Publikováno v:
Alimentary Pharmacology & Therapeutics. 17:719-726
Summary Background : Eradication rates of Helicobacter pylori with standard triple therapy are disappointing, and studies from several countries confirm this poor performance. Aim : To assess the eradication rate of a new sequential treatment regimen
Publikováno v:
Recenti progressi in medicina. 82(5)
We describe a case of necrotizing histiocytic lymphadenitis or Kikuchi and Fujimoto disease, a rare lymphadenopathy of unknown etiology usually striking young women. It was formerly described in Japan, and subsequently in other countries and in Italy
Publikováno v:
Minerva cardioangiologica. 29(11)
Publikováno v:
Acta haematologica. 67(3)
2 cases of acute idiopathic thrombotic thrombocytopenic purpura are reported. Both of them were treated with plasma exchange, antiplatelet drugs and prednisolone and both completely recovered. Plasma exchange appeared to be the critical treatment. In
Publikováno v:
Recenti progressi in medicina. 79(6)
Publikováno v:
Arzneimittel-Forschung. 26(8)
The in vitro effects of N-3-(1-benzyl-cycloheptyloxy)-propyl-N,N-dimethylammonium-hydrogenfumarate (bencyclan) on clotting, fibrinolytic and platelet function test were investigated by adding the drug to normal human plasma. An anticoagulant activity
Publikováno v:
Haematologica. 68(6)
Publikováno v:
Giornale di clinica medica. 58(7-8)
Publikováno v:
Il Farmaco; edizione pratica. 37(10)
Publikováno v:
Thrombosis and Haemostasis Vth Congress.
The responsiveness of fibrinolytic activity and of plasma Factor VIII level to both venous occlusion (v.o.) and i.v. nicotinic acid (N. A.) was investigated in a group of patients with occlusive arterial disease.A marked hyperfibrinolysis, with avera